A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite

Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 5, 2008-04 ,pp. : 399-407

Karger

Access to resources Recommend Favorite

Placebo-controlled Comparison of the Efficacy and Tolerability of Once-daily Moxonidine and Enalapril in Mild to Moderate Essential Hypertension

By Prichard Brian N. C.   Jäger Bodo A.   Luszick Joachim H.   Küster Leslie J.   Verboom Caes N.   Hughes Peter R.   Sauermann Wilhelm   Küppers Hartmut E.  

Blood Pressure, Vol. 11, Iss. 3, 2002-05 ,pp. : 166-172

Informa Healthcare

Access to resources Recommend Favorite

A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo biloba Extract EGb 761^® in Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 4, 2000-06 ,pp. : 230-237

Karger

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite